Inactive Instrument

Yourgene Health

Equities

NIPT

GB00BN31ZD89

Yourgene Health closes GBP1 million retail offer

January 06, 2023 at 09:18 pm

Yourgene Health PLC - Manchester-based molecular diagnostics - Says that its retail offer that was conducted through a bookbuild is now closed. Plans to confirm the results following the conclusion of the general meeting on January 9 at 1600 GMT.

In December, it announced that it planned to raise up to GBP1.0 million from its retail offer.

Current stock price: 0.34p, closed down 5.1% in London on Friday

12-month change: down 97%

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Latest news about Yourgene Health

Yourgene Health Delists Following Novacyt Acquisition	11/09/23	MT
Novacyt: Yourgene officially delisted in London	11/09/23	CF
Novacyt: acquisition of Yourgene Health finalized	08/09/23	CF
Novacyt Completes Acquisition of Yourgene Health	08/09/23	MT
Novacyt completes buy of molecular diagnostics firm Yourgene Health	08/09/23	AN
Novacyt UK Holdings Limited completed the acquisition of Yourgene Health Plc from BGF Investments LP, managed by BGF Investment Management Ltd. and others.	07/09/23	CI
Tintra receives bid approach; NCC trading in line	07/09/23	AN
UK Court OKs Novacyt's Acquisition of Yourgene Health	07/09/23	MT
Yourgene Health Plc Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows	05/09/23	CI
Yourgene, Pathfinder, Spectral MD and Finncap to be deleted on AIM	01/09/23	AN
Correction: Yourgene Health Shareholders Approve Novacyt UK's Takeover Proposal	18/08/23	MT
Yourgene Health Shareholders Approve Novacyt UK's Takeover Proposal	18/08/23	MT
Novacyt takeover of Yourgene Health closer to completion	17/08/23	AN
Ithaca encouraged by K2; Safestyle profit warning	27/07/23	AN
Yourgene Health inks five-year, Illumina contract extension	26/07/23	AN
Yourgene Health plc Signs Five-Year Contract Extension with Illumina Inc	26/07/23	CI
FTSE 100 Closes Down 0.5% On Back of Astrazeneca's Disappointing Lung-Cancer Data	03/07/23	DJ
Miners and oil majors lead FTSE 100 march	03/07/23	AN
Gilt Yields Rise as BOE Rate Expectations Increase	03/07/23	DJ
Novacyt: shares in demand after Yourgene takeover	03/07/23	CF
AIM WINNERS & LOSERS: Yourgene surges on takeover by Novacyt	03/07/23	AN
Yourgene Health agrees to GBP17 million acquisition offer from Novacyt	03/07/23	AN
Stocks start second half in green amid PMIs	03/07/23	AN
Yourgene Health Surges on GBP17 Million Purchase Deal From Novacyt	03/07/23	MT
London Stocks Seen Opening Marginally Higher as 2nd Half Trading Gets Underway	03/07/23	DJ

Chart Yourgene Health

Duration

Period

More charts

Company Profile

Yourgene Health PLC is an integrated molecular diagnostics company. The Company primarily develops, manufactures, and commercializes molecular diagnostic solutions for reproductive health, precision medicine and infectious diseases. Its segments include Genomic Technologies, which provides in vitro diagnostic products, software and instrumentation, and Genomic Services, which provides services to clinicians, third party clinical service providers and contract research organizations. Its flagship products include non-invasive prenatal tests (NIPT) for Down's Syndrome and other genetic disorders, Cystic Fibrosis screening tests, invasive rapid aneuploidy tests, and an extension into the precision medicine space with DPYD genotyping. It has a range of deoxyribonucleic (DNA) sample preparation platforms, powered by Ranger Technology, the Yourgene LightBench and Yourgene QS250, ideal for cell-free DNA applications in non-invasive prenatal tests and oncology, including liquid biopsy.

Sector

More about the company